Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Alveus Pharmaceuticals Private Limited, was an unlisted private company incorporated on 16 October, 2009. It is classified as a private limited company and is located in , Telangana. It's authorized share capital was INR 1.25 cr and the total paid-up capital was INR 14.11 lac.
The current status of Alveus Pharmaceuticals Private Limited is - Strike Off.
Read more
** All rupee values in INR crores.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Srinivasa Rao Vankayalapati | 03256980 | 15 years |
| Director | Komala Devi Vankayalapati | 03429773 | 4 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NEW LINE MEDICINES PRIVATE LIMITED |
Active
|
31.0 L | 2 | Andhra Pradesh |
| ARRIEN INFRASTRUCTURE INDIA PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 2 | Andhra Pradesh |
| ARRIEN-RAJENDRA SPINNING MILLS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
| ARRIEN HOMES PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 2 | Telangana |
| UNITYGROWTH INVESTMENTS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
| OROS PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Telangana |
Read more
The incorporation date of ALVEUS PHARMACEUTICALS PRIVATE LIMITED is 16 October, 2009
The authorized share capital of ALVEUS PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.2 Cr.
The paid-up capital of ALVEUS PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 14.1 L.
The registered address of ALVEUS PHARMACEUTICALS PRIVATE LIMITED is Flat No: 201,3-5-83/7,Virupas MITHILA Apartment Vivekananda Nagar Colony, Kukatpally HYDERABAD Telangana - 500072
The CIN number of ALVEUS PHARMACEUTICALS PRIVATE LIMITED is U24232TG2009PTC065531.